Sugi Predict

Sugi Predict / Compounds / SCHEMBL229034

SCHEMBL229034

SCHEMBL229034

N[C@H]1CC[C@H](CC(=O)O)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ANPEP P15144 1/20 0.52
▸ ENPEP Q07075 1/20 0.52
▸ SLC6A12 P48065 5/20 0.50
▸ SLC6A11 P48066 5/20 0.50
▸ SLC6A13 Q9NSD5 5/20 0.50
▸ SLC6A1 P30531 2/20 0.50
▸ GABRA5 P31644 2/20 0.50
▸ GABRB2 P47870 2/20 0.50
▸ GABRA1 P14867 1/20 0.50
▸ GABRR1 P24046 1/20 0.50
▸ GABRA4 P48169 1/20 0.50
▸ TDP1 Q9NUW8 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ PLG P00747 1/20 0.38
▸ PLAT P00750 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ CPB2 Q96IY4 1/20 0.36
▸ DGAT1 O75907 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL200896 1.00 ANPEP (0.52) ANPEPENPEPSLC6A12SLC6A11SLC6A13
SCHEMBL200897 1.00 ANPEP (0.52) ANPEPENPEPSLC6A12SLC6A11SLC6A13
Hydrochloric Acid SCHEMBL2993122 0.98 ANPEP (0.50) ANPEPENPEPSLC6A12SLC6A11SLC6A13
Hydrochloric Acid SCHEMBL2993124 0.98 ANPEP (0.50) ANPEPENPEPSLC6A12SLC6A11SLC6A13
Hydrochloric Acid SCHEMBL4276196 0.98 ANPEP (0.50) ANPEPENPEPSLC6A12SLC6A11SLC6A13
SCHEMBL3542706 0.93 ANPEP (0.47) ANPEPENPEPSLC6A12SLC6A11SLC6A13
SCHEMBL3542704 0.93 ANPEP (0.47) ANPEPENPEPSLC6A12SLC6A11SLC6A13
Sulfuric Acid SCHEMBL7803541 0.91 ANPEP (0.46) ANPEPENPEPSLC6A12SLC6A11SLC6A13
Sulfuric Acid SCHEMBL4208349 0.91 ANPEP (0.46) ANPEPENPEPSLC6A12SLC6A11SLC6A13
SCHEMBL24483431 0.87 ANPEP (0.56) ANPEPENPEPSLC6A12SLC6A11SLC6A13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122079800-A Preparation method and analysis method of trans-4-amino-cyclohexyl acetic acid — 2026-05-26 — — CN claimed
CN-213132754-U Mechanical stirrer for trans-4-aminocyclohexaneacetic acid production 泰州精英化成医药科技有限公司 2021-05-07 — — CN claimed
EP-1828240-B1 NOVEL MULTIMERIC CD40 LIGANDS, METHOD FOR PREPARING SAME AND USE THEREOF FOR PREPARING DRUGS CENTRE NAT RECH SCIENT (FR) 2009-07-29 — — EP claimed
CN-122079800-A Preparation method and analysis method of trans-4-amino-cyclohexyl acetic acid — 2026-05-26 — — CN disclosed
CN-122079800-A Preparation method and analysis method of trans-4-amino-cyclohexyl acetic acid — 2026-05-26 — — CN disclosed
EP-4709720-A1 INHIBITORS AND DEGRADERS OF PIP4K PROTEIN Larkspur Biosciences, Inc. (US) 2026-03-18 — — EP disclosed
WO-2024233846-A1 INHIBITORS AND DEGRADERS OF PIP4K PROTEIN LARKSPUR BIOSCIENCES, INC. (US) 2024-11-14 — — WO disclosed
WO-2024165072-A1 POLYPEPTIDE COMPOUND AND USE THEREOF 成都纽瑞特医疗科技股份有限公司 2024-08-15 — — WO disclosed
US-20240109881-A1 Heteroaryl Compounds as Ligand Directed Degraders of IRAK4 BRISTOL-MYERS SQUIBB COMPANY (US) 2024-04-04 — — US disclosed
CN-109476617-B Industrial process for preparing cariprazine 吉瑞工厂 2023-04-04 — — CN disclosed
EP-4043446-A2 INDUSTRIAL PROCESS FOR THE PREPARATION OF CARIPRAZINE Richter Gedeon Nyrt. (HU) 2022-08-17 — — EP disclosed
EP-1086084-A1 TETRAISOQUINOLOLINE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS SMITHKLINE BEECHAM PLC (GB) 2001-03-28 — — EP disclosed
EP-1086095-A1 TETRAHYDROISOQUINOLINE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS SMITHKLINE BEECHAM PLC (GB) 2001-03-28 — — EP disclosed
WO-2000024717-A2 ISOQUINOLINE DERIVATIVES SMITHKLINE BEECHAM P.L.C. (GB) 2000-05-04 — — WO disclosed
WO-2000021951-A1 TETRAHYDROBENZAZEPINE DERIVATIVES USEFUL AS MODULATORS OF DOPAMINE D3 RECEPTORS (ANTIPSYCHOTIC AGENTS) SMITHKLINE BEECHAM PLC (GB) 2000-04-20 — — WO disclosed
WO-2000021950-A1 2,3-DIHYDRO-1H-ISOINDOLE DERIVATIVES USEFUL AS MODULATORS OF DOPAMINE D3 RECEPTORS (ANTIPSYCHOTIC AGENTS) SMITHKLINE BEECHAM P.L.C. (GB) 2000-04-20 — — WO disclosed
EP-0983244-A1 TETRAHYDROISOQUINOLINE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS SMITHKLINE BEECHAM PLC (GB) 2000-03-08 — — EP disclosed
WO-1999064412-A1 TETRAHYDROISOQUINOLINE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS SMITHKLINE BEECHAM P.L.C. (GB) 1999-12-16 — — WO disclosed
WO-1999059974-A1 TETRAISOQUINOLOLINE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS SMITHKLINE BEECHAM PLC (GB) 1999-11-25 — — WO disclosed
WO-1998050364-A1 TETRAHYDROISOQUINOLINE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS SMITHKLINE BEECHAM PLC (GB) 1998-11-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240109881-A1 Heteroaryl Compounds as Ligand Directed Degraders of IRAK4 IRAK4, IRAK2, IRAK3 ANPEP 3820/4885ENPEP 2976/4885SLC6A12 4870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.